The Drug Enforcement Administration (DEA) and the Section of Health and Human Products and services (HHS) are committed to ensuring Risk-free and prepared entry to medications for opioid use disorder (MOUD) and have produced a joint letter to all DEA registrants to help make certain that individuals who require buprenorphine can easily accessibilit